TDC
ACHC icon

Thompson Davis & Co’s Acadia Healthcare ACHC Stock Holding History

Thompson Davis & Co’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-207
Closed -$10K – 661
2017
Q3 		$10K Buy
207
+26
+14% +$1.27K 0.02% 677
2017
Q2 		$9K Hold
181
– – 0.01% 674
2017
Q1 		$8K Sell
181
-166
-48% -$6.74K 0.01% 742
2016
Q4 		$11K Buy
347
+181
+109% +$7.02K 0.02% 663
2016
Q3 		$8K Sell
166
-114
-41% -$5.94K 0.01% 704
2016
Q2 		$16K Sell
280
-12
-4% -$702 0.03% 521
2016
Q1 		$16K Sell
292
-172
-37% -$9.82K 0.02% 517
2015
Q4 		$29K Hold
464
– – 0.04% 358
2015
Q3 		$31K Sell
464
-242
-34% -$18.6K 0.04% 349
2015
Q2 		$55K Buy
706
+107
+18% +$7.7K 0.06% 287
2015
Q1 		$43K Buy
599
+349
+140% +$22.4K 0.05% 318
2014
Q4 		$15K Buy
+250
New +$14.6K 0.02% 608
2014
Q1 		– Sell
-250
Closed -$12.3K – 796
2013
Q4 		$12K Buy
+250
New +$10.9K 0.02% 418

Other funds holding ACHC

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PCP
P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Thompson Davis & Co's ACHC Position: Q4 2017 in Review

Thompson Davis & Co sold out of Acadia Healthcare (ACHC) in Q4 2017, closing a stake of 207 shares — an estimated $10K sold.

Thompson Davis & Co first reported a position in ACHC in Q4 2013 and held it in 13 quarters. The position peaked at $55K in Q2 2015. 262 funds tracked by Wall St. Rank hold ACHC as of Q4 2017.

  • Thompson Davis & Co reported no remaining Acadia Healthcare position as of Q4 2017 after selling out during the quarter.
  • Thompson Davis & Co sold 207 Acadia Healthcare shares in Q4 2017, an estimated $10K.
  • Thompson Davis & Co first reported a position in Acadia Healthcare in Q4 2013 and held it in 13 quarters.
  • Thompson Davis & Co's Acadia Healthcare position peaked at $55K in Q2 2015.
  • 262 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2017.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.